Drug Trial Radar · NCT02656485
A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris
Last checked: Nov 19, 2026Latest source record: Apr 5, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Aug 5, 2015
Primary completion
Mar 1, 2016
Study completion Jul 15, 2016
Sponsor
- Lead sponsor
- AOBiome LLCIndustry
- Sponsor type
- Industry
- First posted
- Jan 15, 2016
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single center, randomized, double-blind, placebo-controlled study in subjects with acne vulgaris.
Conditions
- Acne Vulgaris
Interventions
B244Drug
10 pumps (1.4 ml) of spray must be applied BID twice a day to the entire face for 14 days
PlaceboDrug
10 pumps (1.4 ml) of spray must be applied BID twice a day to the entire face for 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety (Number of Participants With Treatment Related Adverse Events)Time frame: 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stephens Associates
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.